Skip to main content
Fig. 2 | BMC Microbiology

Fig. 2

From: Surfactant nanovesicles for augmented antibacterial activity against carbapenemase resistant enterobacteriaceae and extended spectrum beta-lactamases producing bacteria: in vitro and in vivo evaluation

Fig. 2

(a): A representative photo of positive Double Disk Synergy test for an ESBL isolate. (b): A representative photo of modified Hodge test contains reference strains Escherichia coli ATCC 8739 and Klebsiella pneumoniae ATCC 53637. AMC is amoxicillin/clavulanic acid 20/10 µg, CTX is cefotaxime, AX is amoxicillin and MEM is meropenem

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us